Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.729
-4.07 %
$ 21 M
Market Cap
-0.81
P/E
CYTH - COST OF REVENUE
Cost of Revenue CYTH - Cyclo Therapeutics, Inc.
98.5 K
LAST VALUE
-20.58%
2 YEAR CAGR
-1.28%
5 YEAR CAGR
-13.63%
10 YEAR CAGR